Mehrdad Abedi
- Hematology top 1%
- Hematopoietic Stem Cell Transplantation 21
- Acute Myeloid Leukemia Research 11
- Genetics top 1%
- Mesenchymal stem cell research 20
- Virus-based gene therapy research 8
- Chronic Lymphocytic Leukemia Research 8
- Immunology top 5%
- Immunotherapy and Immune Responses 8
- Rehabilitation top 2%
- Oncology top 5%
- CAR-T cell therapy research 25
-
- Acute Lymphoblastic Leukemia research 14
- Co-authors
- William J. MurphyBruce R. BlazarPeter J. QuesenberryGerald A. ColvinEvangelos V. BadiavasVincent FalangaJanet ButmarcMark S. Dooner
- Cited by
- HematologyGeneticsImmunology
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Mehrdad Abedi
86 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 107
- Hematology 823
- Genetics 717
- Immunology 728
- Rehabilitation 201
- Oncology 639
Countries citing papers authored by Mehrdad Abedi
This map shows the geographic impact of Mehrdad Abedi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mehrdad Abedi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mehrdad Abedi more than expected).
Fields of papers citing papers by Mehrdad Abedi
This network shows the impact of papers produced by Mehrdad Abedi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mehrdad Abedi. The network helps show where Mehrdad Abedi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mehrdad Abedi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 1 | |
| 7 | 2021 | 9 | |
| 8 | 2020 | 3 | |
| 9 | 2019 | 25 | |
| 10 | 2014 | 17 | |
| 11 | Intravitreal Autologous Bone Marrow CD34+ Stem Cell Therapy for Macular Degenerative Disease--A Pilot Clinical Trial | 2014 | 1 |
| 12 | Prevalence of musculoskeletal pains among nursing staff in AJA hospitals-Tehran | 2013 | 8 |
| 13 | Determining urine sample mutagenicity ratio using Ames test: Tehran forensic medicine laboratory personnels | 2009 | 2 |
| 14 | 2008 | 24 | |
| 15 | 2005 | 21 | |
| 16 | 2005 | 1 | |
| 17 | 2005 | 51 | |
| 18 | 2005 | 48 | |
| 19 | Epidemiologic study of patients with oesophageal cancer referring to the Babolsar Shahid Rajaii Radiotherapy Center | 2003 | 2 |
| 20 | 2003 | 5 |
About Mehrdad Abedi
Mehrdad Abedi is a scholar working on Hematology, Genetics, Oncology, Immunology and Public Health, Environmental and Occupational Health, having authored 95 papers that have together received 2.6k indexed citations. Recurring topics across this work include CAR-T cell therapy research (25 papers), Hematopoietic Stem Cell Transplantation (21 papers), Mesenchymal stem cell research (20 papers), Acute Lymphoblastic Leukemia research (14 papers), Acute Myeloid Leukemia Research (11 papers), Virus-based gene therapy research (8 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Immunotherapy and Immune Responses (8 papers). The work is most often cited by research in Hematology (823 citations), Genetics (717 citations), Immunology (728 citations), Rehabilitation (201 citations) and Oncology (639 citations). Mehrdad Abedi has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include William J. Murphy, Bruce R. Blazar, Peter J. Quesenberry, Gerald A. Colvin, Evangelos V. Badiavas, Vincent Falanga, Janet Butmarc, Mark S. Dooner, Gerri Dooner and Jean‐François Lambert. Their work appears in journals such as Blood, Journal of Clinical Oncology, Experimental Hematology, Biology of Blood and Marrow Transplantation and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.